Xinyang Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xinyang Chen has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Junhua Xie
State Key Laboratory of Food Science and Resources, Nanchang University, Nanchang, China
3 shared publications Qiqiong Li
2 shared publicationsYushan Xu
2 shared publicationsZe Tao
Nanchang University
2 shared publicationsChunhua Chen
Nanchang University
1 shared publicationKe Zhang
Nanchang University
1 shared publication
Latest Publications
- 21 August 2026
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
Outer Membrane Protein A from Escherichia coli Nissle 1917 Vesicles Alleviates Colon Inflammation by Modulating Specific Inflammatory Signaling Pathway
Inflammatory bowel disease (IBD) is a chronic, relapsing intestinal condition. Probiotic-derived outer membrane vesicles (OMVs) have emerged as a promising postbiotic strategy for IBD. Here, we evaluated the protective effects of Escherichia coli Nissle 1917 (EcN)-derived OMVs in a DSS-induced colitis mouse model using a pretreatment regimen. EcN OMVs attenuated colitis by improving the intestinal barrier and suppressing inflammatory responses, and this anti-inflammatory effect is largely attributed to outer membrane protein A (OmpA). OmpA-carrying EcN OMVs were associated with inhibition of excessive inflammation through a mechanism associated with suppression of TLR4/NF-κB signaling activation. Our work identifies potential mechanisms and key active components by which EcN OMVs may prevent intestinal inflammation. These results underscore the promise of EcN OMVs as functional food ingredients or dietary supplements for gut health maintenance.
- 21 August 2026
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
Outer Membrane Protein A from Escherichia coli Nissle 1917 Vesicles Alleviates Colon Inflammation by Modulating Specific Inflammatory Signaling Pathway
Inflammatory bowel disease (IBD) is a chronic, relapsing intestinal condition. Probiotic-derived outer membrane vesicles (OMVs) have emerged as a promising postbiotic strategy for IBD. Here, we evaluated the protective effects of Escherichia coli Nissle 1917 (EcN)-derived OMVs in a DSS-induced colitis mouse model using a pretreatment regimen. EcN OMVs attenuated colitis by improving the intestinal barrier and suppressing inflammatory responses, and this anti-inflammatory effect is largely attributed to outer membrane protein A (OmpA). OmpA-carrying EcN OMVs were associated with inhibition of excessive inflammation through a mechanism associated with suppression of TLR4/NF-κB signaling activation. Our work identifies potential mechanisms and key active components by which EcN OMVs may prevent intestinal inflammation. These results underscore the promise of EcN OMVs as functional food ingredients or dietary supplements for gut health maintenance.
- 20 August 2026
- Published by Elsevier in Food Bioscience
- Vol. 84
Beyond the gut: The role of Akkermansia muciniphila in neurological health and its application in functional foods
- 20 August 2026
- Published by Elsevier in Food Bioscience
- Vol. 84
Beyond the gut: The role of Akkermansia muciniphila in neurological health and its application in functional foods